SPA
MEDP icon

Sherbrooke Park Advisers’s Medpace MEDP Stock Holding History

Sherbrooke Park Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,186
Closed -$730K – 1005
2024
Q3 		$730K Sell
2,186
-832
-28% -$316K 0.17% 171
2024
Q2 		$1.24M Buy
+3,018
New +$1.2M 0.22% 126

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sherbrooke Park Advisers's MEDP Position: Q4 2024 in Review

Sherbrooke Park Advisers sold out of Medpace (MEDP) in Q4 2024, closing a stake of 2,186 shares — an estimated $730K sold.

Sherbrooke Park Advisers first reported a position in MEDP in Q2 2024 and held it in 2 quarters. The position peaked at $1.24M in Q2 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Sherbrooke Park Advisers reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 2,186 Medpace shares in Q4 2024, an estimated $730K.
  • Sherbrooke Park Advisers first reported a position in Medpace in Q2 2024 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Medpace position peaked at $1.24M in Q2 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.